Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.76 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.69 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.65 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.65 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.65 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.65 |
| ▸ | DPP4 | P27487 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.65 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.65 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.65 |
| ▸ | GAPDH | P04406 | 1/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.65 |
| ▸ | STAT6 | P42226 | 1/20 | 0.65 |
| ▸ | PI4KA | P42356 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.65 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.65 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9231760 | 1.00 | EHMT1 (0.76) | EHMT1RXFP1ADORA1SMN1; SMN2ADORA3 | |
| SCHEMBL10865966 | 0.99 | EHMT1 (0.74) | EHMT1RXFP1ADORA1SMN1; SMN2ADORA3 | |
| SCHEMBL1920531 | 0.99 | EHMT1 (0.74) | EHMT1RXFP1ADORA1SMN1; SMN2ADORA3 | |
| SCHEMBL8671037 | 0.97 | EHMT1 (0.74) | EHMT1RXFP1ADORA1SMN1; SMN2ADORA3 | |
| SCHEMBL8671033 | 0.97 | EHMT1 (0.74) | EHMT1RXFP1ADORA1SMN1; SMN2ADORA3 | |
| SCHEMBL29936475 | 0.97 | EHMT1 (0.74) | EHMT1RXFP1ADORA1SMN1; SMN2ADORA3 | |
| SCHEMBL5562010 | 0.94 | EHMT1 (0.67) | EHMT1RXFP1ADORA1SMN1; SMN2ADORA3 | |
| SCHEMBL2534140 | 0.93 | EHMT1 (0.70) | EHMT1RXFP1ADORA1SMN1; SMN2ADORA3 | |
| SCHEMBL10590849 | 0.91 | EHMT1 (0.66) | EHMT1RXFP1ADORA1SMN1; SMN2ADORA3 | |
| SCHEMBL8970443 | 0.91 | EHMT1 (0.63) | EHMT1RXFP1ADORA1SMN1; SMN2ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4069382-A | 9-(5-O-Acyl-β-D-arabinofuranosyl)adenine compounds | PARKE, DAVIS & COMPANY (US) | 1978-01-17 | — | — | US | claimed |
| US-20110265195-A1 | UNIQUE ASSOCIATED KAPOSI'S SARCOMA VIRUS SEQUENCES AND USES THEREOF | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2011-10-27 | — | — | US | disclosed |
| US-7932066-B2 | Unique associated kaposi's sarcoma virus sequences and uses thereof | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2011-04-26 | — | — | US | disclosed |
| US-20090022748-A1 | Unique associated Kaposi's sarcoma virus sequences and uses thereof | CHANG YUAN | 2009-01-22 | — | — | US | disclosed |
| US-6500663-B1 | TREATING A SUBJECT AFFLICTED WITH A KAPOSI'S SARCOMA CAUSED BY KAPOSI'S SARCOMA ASSOCIATED HERPESVIRUS WHICH COMPRISES ADMINISTERING A NUCLEOSIDE ANALOG OR AN ANTISENSE NUCLEIC ACID | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2002-12-31 | — | — | US | disclosed |
| US-6348586-B1 | NUCLEOTIDE SEQUENCE OF HERPES VIRUS; DIAGNOSIS; VACCINES; VIRICIDES; ANTISENSE AGENTS; TRIPLEX OLIGONUCLEOTIDES; | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2002-02-19 | — | — | US | disclosed |
| US-6183751-B1 | VACCINES; DIAGNOSIS; OPEN READING FRAME; GENETIC ENGINEERING | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2001-02-06 | — | — | US | disclosed |
| US-6150093-A | NUCLEOTIDE SEQUENCES PREFERENTIAL FOR HERPES VIRUS ASSOCIATED WITH A CANCER; FOR TREATMENT, DIAGNOSIS AND DETECTION OF AQUIRED IMMUNODEFICIENCY SYNDROME RELATED CANCER | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2000-11-21 | — | — | US | disclosed |
| US-6093550-A | DIAGNOSING KAPOSI'S SARCOMA(KS) ASSOCIATED HERPESVIRUS INFECTION BY CONTACTING A SAMPLE WITH A KS ASSOCIATED HERPESVIRUS ANTIGEN, DETERMINING THE LEVEL OF KS ASSOCIATED HERPESVIRUS ANTIBODY BOUND TO THE ANTIGEN; IMMUNOASSAY KITS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2000-07-25 | — | — | US | disclosed |
| EP-0804547-A4 | UNIQUE ASSOCIATED KAPOSI'S SARCOMA VIRUS SEQUENCES AND USES THEREOF | UNIV COLUMBIA (US) | 1999-11-03 | — | — | EP | disclosed |
| WO-1998004576-A1 | UNIQUE ASSOCIATED KAPOSI'S SARCOMA VIRUS SEQUENCES AND USES THEREOF | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1998-02-05 | — | — | WO | disclosed |
| EP-0804547-A1 | UNIQUE ASSOCIATED KAPOSI'S SARCOMA VIRUS SEQUENCES AND USES THEREOF | The Trustees of Columbia University in the City of New York (US) | 1997-11-05 | — | — | EP | disclosed |
| WO-1997027208-A1 | UNIQUE ASSOCIATED KAPOSI'S SARCOMA VIRUS SEQUENCES AND USES THEREOF | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1997-07-31 | — | — | WO | disclosed |
| EP-0726708-A1 | VIRUS ASSOCIATED MULTIPLE SCLEROSIS: TREATMENTS, PREVENTION AND DIAGNOSIS THEREOF | PATHOGENESIS CORPORATION (US) | 1996-08-21 | — | — | EP | disclosed |
| WO-1996015779-A1 | UNIQUE ASSOCIATED KAPOSI'S SARCOMA VIRUS SEQUENCES AND USES THEREOF | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1996-05-30 | — | — | WO | disclosed |
| WO-1996006159-A1 | UNIQUE ASSOCIATED KAPOSI'S SARCOMA VIRUS SEQUENCES AND USES THEREOF | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1996-02-29 | — | — | WO | disclosed |
| WO-1995012313-A1 | VIRUS ASSOCIATED MULTIPLE SCLEROSIS: TREATMENTS, PREVENTION AND DIAGNOSIS THEREOF | PATHOGENESIS CORPORATION (US) | 1995-05-11 | — | — | WO | disclosed |
| EP-0317728-A2 | Use of 9-(beta-D-arabinofuranosyl) adenine derivatives for the preparation of pharmaceutical compositions for the treatment of aids | WARNER-LAMBERT COMPANY (US) | 1989-05-31 | — | — | EP | disclosed |
| US-4069382-A | 9-(5-O-Acyl-β-D-arabinofuranosyl)adenine compounds | PARKE, DAVIS & COMPANY (US) | 1978-01-17 | — | — | US | disclosed |
| US-4069382-A | 9-(5-O-Acyl-β-D-arabinofuranosyl)adenine compounds | PARKE, DAVIS & COMPANY (US) | 1978-01-17 | — | — | US | disclosed |